Alain B Schreiber

Title: The Innovative Contributions of Alain B Schreiber

Introduction

Alain B Schreiber is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of medical diagnostics, particularly in the detection of malignant conditions. With a total of 3 patents to his name, Schreiber's work has the potential to impact patient care and treatment outcomes.

Latest Patents

One of Schreiber's latest patents is a method for determining the presence of malignant cells. This invention focuses on a method for identifying malignant conditions at a specific locus of interest. An exfoliative cell specimen obtained from the locus is treated with an antibody that specifically binds to an antigenic site typically present only when a malignant condition exists. The binding of the antibody to the antigenic site is observed, which correlates with the presence of malignancy. This method is particularly useful in detecting cervical carcinoma. Another significant patent involves polypeptide analogs of fragments of transforming growth factor alpha (TGF.alpha.) and epidermal growth factor (EGF), which serve as therapeutic and diagnostic agents.

Career Highlights

Alain B Schreiber has worked at Syntex (U.S.A.) Inc., where he has been able to apply his innovative ideas in a corporate setting. His work has contributed to advancements in medical technology and diagnostics.

Collaborations

Throughout his career, Schreiber has collaborated with notable colleagues, including John J Nestor and William J Kowalski. These collaborations have likely enhanced the development and implementation of his innovative ideas.

Conclusion

Alain B Schreiber's contributions to the field of medical diagnostics through his patents demonstrate his commitment to innovation and improving patient care. His work continues to influence the medical community and offers promising advancements in the detection of malignant conditions.